Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT03325816 · COMPLETED
Trial details
- NCT number
- NCT03325816
- Sponsor
- Georgetown University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-20
- Primary completion
- 2019-03-28
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.